Press Releases

Vital Images, Inc. a Minneapolis-based advanced medical imaging and informatics company, will feature its enterprise interoperability solutions at the HIMSS Asia Pacific annual conference in booth 412, 23-26 August in Bangkok, Thailand. Vital's healthcare imaging informatics...

Arizona Instrument LLC is proud to announce the release of the Computrac® Vapor Pro® XL – the latest in a long line of accurate, reliable and easy to use moisture analyzers. About the Vapor Pro® XLThe...

Pfizer Inc announced that the U.S. Food and Drug Administration (FDA) has approved Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) extended-release capsules, for oral use, CII for the management of pain severe enough to require daily. ...

  AstraZeneca announced results from the Phase III SELECT-1 trial of the MEK 1/2 inhibitor, selumetinib, in combination with docetaxel chemotherapy as 2nd-line treatment in patients with KRAS mutation-positive (KRASm) locally-advanced or metastatic non-small cell lung cancer (NSCLC). ...

Biogen announced that Bioverativ will be the name of the standalone, publicly-traded global biotechnology company that it expects to launch in early 2017. Bioverativ will be focused on the discovery, research, development and commercialization of treatments for hemophilia and...

Takeda Pharmaceutical Company Limited announced Takeda Canada has received approval from Health Canada for NINLARO™ (ixazomib) capsules in combination with lenalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior...

Merck known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 (programmed death receptor-1) therapy, at a fixed dose of 200...